The diagnosis and treatment of delirium in children

Sean Hatherill1, Alan J Flisher, Rene Nassen

  • 1a Division of Child and Adolescent Psychiatry , Red Cross War Memorial Children's Hospital and University of Cape Town , Rondebosch , 7701 , South Africa.

Insights

Delirium in children is often misdiagnosed due to challenges in applying standard criteria. This study offers a practical guide for identifying pediatric delirium symptoms and a treatment algorithm, including when to use antipsychotics.

Area of Science:

  • Child and Adolescent Psychiatry
  • Pediatric Neurology
  • Behavioral Pediatrics

Background:

  • Delirium is frequently observed in pediatric consultation-liaison psychiatry.
  • Current diagnostic criteria for delirium are often difficult to apply in children, leading to misdiagnosis.

Purpose of the Study:

  • To present a practical approach for identifying signs and symptoms of delirium in pediatric patients.
  • To propose a treatment algorithm for pediatric delirium.

Main Methods:

  • Development of a practical approach to elicit delirium signs and symptoms in children.
  • Creation of a treatment algorithm incorporating environmental management and pharmacotherapy guidelines.

Main Results:

  • The proposed approach facilitates the identification of delirium in pediatric cases.
  • The treatment algorithm provides clear thresholds for antipsychotic medication use.

Conclusions:

  • A structured approach can improve the diagnosis of delirium in children.
  • The proposed algorithm aids in managing pediatric delirium effectively, guiding environmental and pharmacological interventions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
680
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
792